Photocurable Poly(siloxane) Resin for Biocompatible SL 3D Printing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current stereolithography (SL) 3D printing methods for microfluidic systems face limitations due to the lack of biocompatibility, transparency, and gas permeability in commercially available resins, which hinder the creation of complex geometries and lead to cytotoxicity issues in cell culture applications, making them inferior to PDMS devices.

Innovation Solution

Development of photocurable poly(siloxane) formulations for SL 3D printing that include a first polymerizable poly(siloxane) with terminal polymerizable groups, a second polymerizable poly(siloxane) with side-chain polymerizable groups, and a photo-initiator, along with optional photo-sensitizers and ultraviolet light absorbers, to create PDMS structures with improved mechanical and optical properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Extent of automation

If commercial SL resins are used for 3D printing, then automated 3D fabrication is achieved, but biocompatibility and transparency are lost

Engineering Contradiction:
Improveautomated 3D fabricationVSAvoidbiocompatibility
Core Design Contradiction:
Extent of automationVSReliability

Solution Approach 1:

The patent changes the chemical composition parameters of the resin by incorporating biocompatible photopolymerizable compounds and specific photoinitiators that do not release toxic leachates, while maintaining the automated SL printing process. This resolves the contradiction by modifying material parameters to achieve both automation and biocompatibility.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite resin formulation combining multiple photopolymerizable compounds with specific photoinitiators to achieve desired properties. The composite material provides both the automation capability of SL printing and the biocompatibility required for cell culture applications.

Inventive Principle:
Principle #40Composite materials

2Extent of automation

If commercial SL resins are used for 3D printing, then automated 3D fabrication is achieved, but optical transparency is reduced

Engineering Contradiction:
Improveautomated 3D fabricationVSAvoidoptical transparency
Core Design Contradiction:
Extent of automationVSIllumination intensity

Solution Approach 1:

The patent adjusts the chemical composition parameters of the resin to improve optical transparency while maintaining automated SL fabrication. By selecting specific photopolymerizable compounds and photoinitiators with appropriate absorption characteristics, the resin achieves better transparency for optical applications.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If manual PDMS molding is used, then biocompatibility and gas permeability are achieved, but fabrication time increases

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidfabrication time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent replaces the manual mechanical molding process with automated stereolithography 3D printing. The SL process uses photopolymerization chemistry instead of manual molding operations, dramatically reducing fabrication time while maintaining biocompatibility through careful selection of biocompatible resin components.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fabrication process parameters from manual molding to automated photopolymerization, reducing fabrication time. The resin composition is optimized to cure properly through photopolymerization while maintaining the biocompatibility characteristics of PDMS.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If manual PDMS molding is used, then biocompatibility and gas permeability are achieved, but device complexity is limited

Engineering Contradiction:
ImprovebiocompatibilityVSAvoid3D geometries
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces the layer-by-layer manual molding approach with automated stereolithography 3D printing, which can fabricate complex three-dimensional geometries in a single continuous process. This substitution enables production of complex microfluidic devices with internal channels and multi-level structures while maintaining biocompatibility.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

5Shape

If micromilling is used for fabrication, then complex geometries are achieved, but assembly and bonding are still required

Engineering Contradiction:
Improvecomplex geometriesVSAvoidassembly and bonding
Core Design Contradiction:
ShapeVSEase of manufacture

Solution Approach 1:

The patent merges the channel formation and device fabrication into a single SL 3D printing process. The photopolymerizable resin is printed directly into the final device geometry with integrated channels, eliminating the need for separate assembly and bonding steps required by micromilling approaches.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent replaces the mechanical micromilling and assembly process with automated photopolymerization-based SL printing. This substitution creates complex geometries in a single additive manufacturing step, eliminating subsequent assembly operations.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution enables the production of SL 3D-printed PDMS structures that are biocompatible, optically transparent, and elastomeric, with tunable elasticity and enhanced resolution, overcoming the limitations of existing SL resins and achieving performance comparable to thermally cured PDMS devices.

Implementation Method 1

photocurable poly(siloxane) formulations for making stereolithographic (SL) 3D-printed PDMS structures

Methodology Applied
Scientific EffectPhotopolymerization: Photopolymerisation

Data Source

PatentUS11104802B2PDMS resin for stereolithographic 3D-printing of PDMS
Publication Date: 2021.08.31 UNIV OF WASHINGTON
  • US11104802B2 patent drawing
  • US11104802B2 patent drawing
  • US11104802B2 patent drawing

AI summary

Photocurable poly(siloxane) formulations for making stereolithographic 3D-printed PDMS structures, stereolithographic 3D-printing methods for making PDMS structures, and stereolithographic 3D-printed PDMS structures.